Key Takeaways & Executive Findings
- β’β’ Fluorogenic RNA aptamers enable live-cell RNA imaging with high spatiotemporal resolution by significantly enhancing fluorophore fluorescence upon binding. β’ Structural studies reveal that many fluorogenic RNA aptamers utilize base quadruples and base triples in their fluorophore-binding sites, which are critical for ligand recognition and fluorescence activation. β’ The review highlights how tertiary structure information guides rational optimization of aptamers and fluorophores, improving photophysical properties for biosensing and bioimaging applications. β’ Recent aptamers such as Pepper and Clivia offer high cellular brightness, good photostability, and multiple spectral properties, expanding the RNA imaging toolbox.
Abstract
Fluorogenic RNA aptamers are in vitro-selected RNA molecules capable of binding to specific fluorophores, significantly increasing their intrinsic fluorescence. Over the past decade, the color palette of fluorescent RNA aptamers has greatly expanded. The emergence and development of these fluorogenic RNA aptamers has introduced a powerful approach for visualizing RNA localization and transport with high spatiotemporal resolution in live cells. To date, a variety of tertiary structures of fluorogenic RNA aptamers have been determined using X-ray crystallography or NMR spectroscopy. Many of these fluorogenic RNA aptamers feature base quadruples or base triples in their fluorophore-binding sites. This review summarizes the structure-based investigations of fluorogenic RNA aptamers, with a focus on their overall folds, ligand-binding pockets and fluorescence activation mechanisms. Additionally, the exploration of how structures guide rational optimization to enhance RNA visualization techniques is discussed.
1. Introduction
RNA is one of the most fundamental biomacromolecules in life and plays a crucial role in diverse biological processes, such as genetic information translation, gene expression regulation, and maintenance of cell functionality [1β4]. The visualization of RNA localization and dynamics with high spatial and temporal resolution is essential for investigating their functions, mechanisms and interactions in biology. Fluorescent proteins, especially green fluorescent protein (GFP), have revolutionized the spatiotemporal localization of proteins and the investigation of protein interactions both in vivo and in vitro [5β8]. However, intrinsic fluorescent RNAs comparable to GFP have not been identified until now. Current techniques used for the dynamic detection of RNA molecules include fluorescence in situ hybridization (FISH) [9,10], molecular behavior technology [11], and RNA hairpin methods [12β18]. While effective, FISH requires cell fixation and cannot be used for live-cell imaging [9,10]. Molecular behavior technology allows spatiotemporal imaging of RNA molecules in living cells but is limited by false-positive signals [11]. Alternatively, RNAs of interest can be labelled with naturally occurring RNA hairpins along with their specific binding proteins (e.g., MS2-MCP [12], PP7-PCP [14], Ξ»N22-boxB [15] and gRNA-dCas [16β18]) fused to fluorescent proteins. Unfortunately, this technique suffers from the high background fluorescence of unbound fluorescent proteins. Recently, RNA-based fluorogenic aptamers have been used for advanced live-cell RNA imaging [19β28]. These fluorogenic RNA aptamers, which evolved in vitro through Systematic Evolution of Ligands by Exponential Enrichment (SELEX) technology, can specifically bind to their cognate fluorogenic dyes and significantly activate their fluorescence [29β32].
The Malachite Green aptamer was the first fluorescent RNA aptamer, originally developed in 2003 [33,34]. In 2011, the Jaffrey group synthesized a series of fluorogenic HBI analogues and selected an RNA mimic of GFP called Spinach, marking a critical breakthrough in the development of fluorogenic RNA aptamers [35]. Since then, various approaches have been employed to fine-tune and improve the properties of Spinach and its cognate fluorophore molecules, leading to the identification of related aptamers such as Broccoli [36], Corn [37], Beetroot [38], Chili [39] and Squash [40] aptamers. In addition, multiple other fluorescent RNA aptamer systems have been isolated and characterized, including cyanine dye-based aptamers [41β44], contact quenching-based aptamers [45β52], and spirolactonization-based aptamers [53,54]. Recently, two novel fluorogenic aptamers, Pepper and Clivia, which feature high cellular brightness, good photostability and multiple spectral properties, have been developed, greatly enriching the available toolbox for RNA imaging [55β57].
Loading authentic research manuscript (Pages 1β5)...
Qianqian Song, Xiaoqing Tai, Qianyu Ren, Aiming Ren (2026). Structure-based insights into fluorogenic RNA aptamers. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2024142
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are fluorogenic RNA aptamers?
Fluorogenic RNA aptamers are in vitro-selected RNA molecules that bind to specific fluorophores and significantly enhance their fluorescence, enabling live-cell RNA imaging with high spatiotemporal resolution.
How do fluorogenic RNA aptamers work?
They specifically bind to cognate fluorogenic dyes, such as HBI analogues or other fluorophores, and activate their fluorescence through structural interactions, often involving base quadruples or triples in the binding pocket.
What structural features are common in fluorogenic RNA aptamers?
Many fluorogenic RNA aptamers feature base quadruples or base triples in their fluorophore-binding sites, which are crucial for ligand recognition and fluorescence activation.
Why are structural studies important for fluorogenic RNA aptamers?
Structural studies provide insights into the mechanisms of ligand recognition and fluorescence activation, guiding rational optimization of aptamers and fluorophores for improved photophysical properties and applications in biosensing and bioimaging.
What are some recent advances in fluorogenic RNA aptamers?
Recent aptamers such as Pepper and Clivia offer high cellular brightness, good photostability, and multiple spectral properties, greatly enriching the RNA imaging toolbox.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.